Literature DB >> 28218009

The use of social media by adults with acquired conditions who use AAC: current gaps and considerations in research.

Helen L Paterson1.   

Abstract

The global growth and development of social media has had a positive impact on many individuals who use augmentative and alternative communication (AAC), who use it to communicate and connect with others. Research evidence into the use of social media by adults with acquired conditions who use AAC is limited. These individuals are a heterogeneous population, who can present with a range of linguistic, cognitive and physical needs, some of which progress rapidly, making accessing social media a challenge. These issues warrant research focusing on developing interventions to support the use of social media and the impact of these interventions. For individuals with acquired conditions who have previously used social media and for those who are new to the experience, social media can offer a vital connection to friends, family and health professionals. This paper examines current gaps in knowledge in this area in the field of AAC and proposes potential methodologies for future research. These include combining qualitative and quantitative methodologies (e.g., analysis of online interactions and observational data) that would be useful tools for data collection in an under-researched field.

Keywords:  Augmentative and alternative communication; acquired conditions; social media

Mesh:

Year:  2017        PMID: 28218009     DOI: 10.1080/07434618.2016.1275789

Source DB:  PubMed          Journal:  Augment Altern Commun        ISSN: 0743-4618            Impact factor:   2.214


  1 in total

1.  'I kind of figured it out': the views and experiences of people with traumatic brain injury (TBI) in using social media-self-determination for participation and inclusion online.

Authors:  Melissa Brunner; Stuart Palmer; Leanne Togher; Bronwyn Hemsley
Journal:  Int J Lang Commun Disord       Date:  2018-06-05       Impact factor: 3.020

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.